Russia’s president flattered his American counterpart as “smart” and “pragmatic,” and repeated Mr. Trump’s baseless claim ...

A debate over the program for skilled foreign workers has pitted immigration hard-liners against some of President Trump’s ...

Top advisers to Robert F. Kennedy Jr. are battling over how aggressively to target vaccines during his first days as the ...

Ascentage Pharma Group (AAPG) (AAPGV) (ASPHF), which is backed by Takeda (TAK), has priced a $126M U.S. initial public offering. Read more here.

Merck (MRK) and Eisai (ESAIY) announced results from the Phase 3 LEAP-015 trial evaluating KEYTRUDA, Merck’s anti-PD-1 therapy, plus LENVIMA, ...

Merck's blockbuster drug Keytruda and Eisai's cancer drug Lenvima, in combination with chemotherapy, failed to improve ...

He may have been only a virtual attendee, but the lines to see Donald J. Trump address the World Economic Forum stretched ...

Trump then went on to criticize the nation’s electric grid, calling it old while noting that he would allow the tech companies to rely on any fuel that they want to run the plants. And if the energy ...

The latest health news includes Robert F. Kennedy Jr.'s nomination, Abbott's strategy amid global challenges, and Purdue Pharma's opioid settlement. It highlights company strategies, profits, and ...

Robert F. Kennedy Jr. is distancing himself from his anti-vaccine work as he seeks to become the leader of the nation’s top health agency under President Donald Trump, according to reports.

Robert F. Kennedy Jr. is backing away from his anti-vaccine work as he vies for leadership of the Health and Human Services ...

Kennedy Jr.'s HHS nominee hearing with the U.S. Senate Finance Committee is set for Jan. 29. (FirstWord Pharma) Ahead of this ...